Gufic Biosciences Ltd (BOM:509079)
₹ 405.65 5.4 (1.35%) Market Cap: 40.68 Bil Enterprise Value: 44.00 Bil PE Ratio: 46.68 PB Ratio: 7.64 GF Score: 93/100

Q1 2022 Gufic Biosciences Ltd Earnings Call Transcript

Aug 12, 2021 / 11:30AM GMT
Release Date Price: ₹217.75 (+13.29%)
Operator

Ladies and gentlemen, good day, and welcome to the Q1 FY 2022 earnings conference call of Gufic Biosciences Limited. (Operators Instructions) Please note this conference is being recorded. I now hand the conference over to Ms. Ami Shah, Company Secretary, Gufic Biosciences Limited. Thank you, and over to you, Ms. Shah.

Ami Shah
Gufic Biosciences Limited - Company Secretary & Compliance Officer

Thank you so much. Good evening, everyone. I am Ms. Ami Shah, Company Secretary of Gufic Biosciences Limited. Welcome you all to Q1 FY 2022 earnings conference call of Gufic Biosciences Limited. I have with me Mr. Pranav J. Choksi, Chief Executive Officer and Director; Mr. Devkinandan Roonghta, Chief Financial Officer; Mr. Nagesh Y, Chief Operating Officer; and Mr. Avik Das from Investor Relations team to give the highlights of the business performance of the company and to clarify the queries of the investors during the call. We'll begin the call with opening remarks from the management, followed by Q&A session.

Before proceeding, I would like to draw

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot